Osteopenia and Osteoporosis

Slide 1 · Osteopenia and Osteoporosis

Bone mass, remodeling, morphology and fracture risk

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define osteopenia and osteoporosis and distinguish them from defective mineralization.

Explain age-, estrogen-, nutrition-, and loading-related bone loss.

Identify trabecular and cortical morphology and relate architecture to fractures.

Interpret diagnostic methods and connect mechanisms to prevention and therapy.

Slide 3 · The central pathologic lesion

Osteopenia signifies a reduction in the quantity of bone.

Osteoporosis is sufficiently severe loss of bone mass to increase fracture risk.

In osteoporosis, the remaining bone is histologically normal in composition.

Loss of structural support—not abnormal mineralization—is the defining problem.

Slide 4 · Bone mass versus mineralization

Condition

Bone quantity

Mineralization of existing matrix

Normal bone

Maintained

Normal

Osteoporosis

Decreased

Normal

Osteomalacia

Can be variable

Defective

Slide 5 · Why bone mass does not tell the whole story

Bone mass reflects the cumulative balance between matrix formation and removal.

Trabecular connectivity and cortical thickness determine structural strength.

Architectural deterioration makes the skeleton fragile even when residual bone looks normal.

Fracture is the consequential clinical expression of osteoporosis.

Slide 6 · Bone-density categories in the text

Classification

Density relative to young-adult mean

Low bone mass (osteopenia)

Between 1 and 2.5 standard deviations below

Osteoporosis

At least 2.5 standard deviations below

Slide 7 · Interpreting density thresholds

The comparison uses a young-adult reference distribution.

A bone-density category is a measurement classification, not a description of fracture location.

Low bone mass and osteoporosis form a continuum of skeletal loss.

Clinical interpretation should not ignore fracture history or competing causes of fragility.

Slide 8 · Distribution of osteoporosis

Dimension

Localized loss

Generalized loss

Distribution

One bone or region

Multiple skeletal sites

Illustration

Immobilized limb

Postmenopausal or senile bone loss

Mechanistic emphasis

Reduced mechanical stimulation

Systemic loss of remodeling balance

Slide 9 · Primary and secondary generalized osteoporosis

Primary forms

Secondary forms

Idiopathic, postmenopausal, senile

Underlying endocrine, neoplastic, gastrointestinal or systemic disease

Dominant drivers: aging and estrogen deficiency

Can also follow medications or immobilization

Slide 10 · Why peak bone mass matters

Peak bone mass is reached in young adulthood, after skeletal growth.

The amount accrued provides a reserve against later resorptive loss.

Lower peak mass increases vulnerability even if later bone-loss rates are ordinary.

Peak bone mass and subsequent loss jointly influence adult fracture susceptibility.

Slide 11 · Determinants of peak bone mass

Genetic variation

Nutrition

Physical loading

Hormonal state

Peak bone mass

Hereditary influences, physical activity, nutrition and hormones jointly set the initial skeletal reserve.

An unfavorable combination leaves less bone to lose in later life.

Slide 12 · Skeletal mass changes across adult life

After peak skeletal mass, resorption begins to exceed formation slightly.

Average age-related loss of about 0.7% each year.

Both sexes are affected by age-dependent skeletal mass decline.

Menopause can superimpose an accelerated resorptive phase in women.

Slide 13 · Bone remodeling is continuous

Adult bone renews within coordinated basic multicellular units.

Osteoclasts remove mineralized tissue; Osteoblasts replace matrix.

The normal sequence couples resorption and deposition.

An imbalance sustained over time progressively diminishes bone mass.

Slide 14 · Sequence within a remodeling unit

Osteoclast attachment

Bone resorption

Osteoblast recruitment

Matrix deposition

Coupled remodeling preserves the skeleton when formation replaces resorbed bone.

Slide 15 · Bone cells: Distinct responsibilities

Osteoclast

Osteoblast

Osteocyte

Resorbs mineralized bone

Synthesizes new bone matrix

Senses mechanical loading

From hematopoietic lineage

From osteoprogenitor lineage

Embedded within bone

Regulated by RANK signaling

Responds to Wnt and growth signals

Controls remodeling response to load

Slide 16 · The RANK–RANKL signal drives osteoclasts

Osteoblast / stromal cell

RANKL

Osteoclast precursor

RANK receptor

Mature osteoclast

Resorption

RANK signaling → NF-κB activation

RANK is expressed by osteoclast precursors; RANKL is expressed by osteoblasts and marrow stromal cells.

RANK signaling through NF-κB supports osteoclast differentiation and survival.

Slide 17 · Osteoprotegerin restrains resorption

RANKL

RANK on precursor

OPG decoy receptor

OPG sequesters RANKL; Receptor signaling is limited

OPG is a soluble decoy receptor produced in the skeletal microenvironment.

By binding RANKL, OPG reduces its interaction with RANK and limits osteoclastogenesis.

Slide 18 · Wnt signaling favors bone formation

Wnt ligand

LRP5/6 · β-catenin

Osteoblast output / OPG

Osteocyte-derived sclerostin

Sclerostin limits Wnt-dependent formation

Wnt–LRP5/6–β-catenin signaling supports osteoblast function and OPG synthesis.

Osteocyte-derived sclerostin inhibits Wnt signaling and reduces formation.

Slide 19 · Remodeling balance integrates systemic signals

PTH, glucocorticoids, inflammatory cytokines and sex hormones can shift remodeling.

Local OPG, RANKL and Wnt signals mediate many of these systemic effects.

Effects differ by the signal and the cellular compartment involved.

Osteoporosis results from an unfavorable net balance, not a single universal cellular defect.

Slide 20 · Two common pathogenic patterns

Postmenopausal osteoporosis

Senile osteoporosis

Estrogen decline dominates

Aging of osteoblast lineage dominates

Osteoclast-driven resorption increases

Osteoblast synthetic capacity decreases

High-turnover phenotype

Low-turnover phenotype

Cancellous bone particularly susceptible

Cortical thinning becomes prominent

Slide 21 · Senile osteoporosis: Impaired replacement

Skeletal aging

Osteoprogenitor

Replication ↓

Osteoblast matrix

Synthesis ↓

Growth-factor

Responsiveness ↓

Bone formation ↓

Older osteoblasts exhibit lower proliferation and biosynthetic activity.

The response to growth factors is attenuated; Formation no longer fully replaces resorption.

Slide 22 · Osteoprogenitors and skeletal aging

Replicative activity of osteoprogenitor cells declines with age.

The pool able to differentiate into active osteoblasts becomes less productive.

Matrix synthesis following bone resorption becomes less complete.

Age-related bone loss can occur even without an abrupt hormonal change.

Slide 23 · Growth-factor response falls with aging

Osteoblasts in older adults have attenuated responses to matrix-derived growth factors.

Paracrine coupling becomes less effective at restoring resorbed bone.

Reduced anabolic output creates a low-turnover imbalance.

The morphologic endpoint is decreased skeletal quantity.

Slide 24 · Mechanical load is a remodeling signal

Skeletal loading

Osteocyte signal

Adaptive remodeling

Unloading / immobility

Altered osteocyte input

Bone mass declines

Osteocytes sense loading and influence osteoblasts and osteoclasts.

Decreased use changes local remodeling in favor of loss.

Slide 25 · Disuse osteoporosis

An immobilized or paralyzed limb loses bone locally.

Decreased osteocyte loading signals reduce the stimulus for maintenance.

Prolonged unloading can diminish skeletal mass without a systemic hormone defect.

This illustrates the mechanostat contribution to osteoporosis.

Slide 26 · Loading magnitude influences adaptation

The text distinguishes magnitude of load from number of loading cycles.

Resistance activity supplies relatively high-magnitude skeletal loading.

Repetitive endurance activity with low skeletal loading may be a weaker density stimulus.

Exercise effects depend on the mechanical stresses imposed on bone.

Slide 27 · Examples of loading environments

Environment

Predicted skeletal response

Immobilized extremity

Localized bone loss

Microgravity

Generalized skeletal unloading and bone loss

Athletic high-load training

Adaptation favoring higher density

Slide 28 · Genetics: Susceptibility is usually polygenic

Single-gene disorders cause only a small minority of osteoporosis cases.

Common polymorphisms influence peak bone mass and remodeling susceptibility.

Genome-wide association signals implicate RANK, RANKL and OPG.

The estrogen-receptor locus and HLA region also show associations.

Slide 29 · Genetic associations are not deterministic

RANK-axis genes encode major regulators of osteoclast activity.

A statistical association does not imply that most osteoporosis has a single-gene cause.

The mechanism of the HLA association is described as uncertain.

Environmental loading and nutrition modify inherited susceptibility.

Slide 30 · Calcium during skeletal accrual

Inadequate calcium intake during adolescence can reduce achieved peak bone mass.

Low peak mass increases later-life fragility vulnerability.

The effect extends beyond the period of initial nutritional insufficiency.

Prevention begins before the years in which fractures commonly appear.

Slide 31 · Calcium, vitamin D and PTH with aging

Relative calcium deficiency can contribute to senile osteoporosis.

Reduced vitamin D availability can coexist with aging-related bone loss.

Compensatory PTH elevation may favor resorption.

These influences may interact with declining osteoblast formation.

Slide 32 · Estrogen normally favors skeletal retention

Estrogen

RANKL expression ↓

Osteoclast apoptosis ↑

Osteoblast apoptosis ↓

Net maintenance

Of bone mass

Estrogen promotes osteoclast apoptosis and suppresses RANKL production.

It also inhibits osteoblast apoptosis, supporting formation.

Slide 33 · After menopause: Signaling shifts

Estrogen ↓

IL-1, IL-6, TNF / IL-17 ↑

RANKL ↑ / OPG ↓

Resorption ↑

High-turnover osteoporosis: Resorption exceeds formation

Estrogen deficiency increases osteoclast recruitment and activity.

Resorption increases more than formation, producing high-turnover loss.

Slide 34 · Inflammatory pathways after menopause

Higher IL-1, IL-6 and TNF production by innate immune cells.

Increased IL-17 production by Th17 cells also contributes.

The upstream mechanism for these cytokine changes is not fully resolved.

Inflammatory signaling shifts RANKL and OPG toward osteoclast activation.

Slide 35 · From estrogen withdrawal to bone loss

Reduced estrogen

Cytokines / RANKL increase

Osteoclast activity rises

Net trabecular loss

This schematic summarizes the high-turnover mechanism; The cytokine drivers are multiple.

Slide 36 · Formation rises, yet net mass falls

Estrogen deficiency may increase both formation and resorption.

The resorptive response is quantitatively dominant.

The mismatch explains high-turnover postmenopausal osteoporosis.

A rise in turnover alone does not guarantee increased bone mass.

Slide 37 · Early postmenopausal skeletal loss

Accelerated loss during the decade after menopause.

Under the described circumstances, annual loss may reach 2% of cortical and 9% of cancellous bone.

These are possible rates cited by the textbook, not universal individual trajectories.

The marked cancellous vulnerability helps explain vertebral fragility.

Slide 38 · Aging versus menopause: Mechanistic contrast

Feature

Age-associated pathway

Postmenopausal pathway

Dominant imbalance

Formation is reduced

Resorption rises disproportionately

Cellular driver

Osteoblast dysfunction

Increased osteoclastogenesis

Turnover label

Low turnover

High turnover

Emphasized morphology

Cortical thinning

Trabecular plate loss

Slide 39 · Secondary osteoporosis: Why assess causes?

Not all generalized osteoporosis is primary.

Endocrine disease, systemic illness, neoplasia, medication exposure and immobility may contribute.

A secondary process may coexist with age-related or postmenopausal loss.

Recognizing the cause is essential for clinicopathologic interpretation.

Slide 40 · Secondary causes: Endocrine disorders

Endocrine examples

Pathologic concern

Hyperparathyroidism

Resorptive effects of excess PTH

Hyperthyroidism

Altered bone turnover

Type 1 diabetes

Systemic metabolic influence on skeletal health

Adrenal and pituitary disorders

Secondary hormonal contribution

Slide 41 · Secondary causes: Nutrition and gastrointestinal disease

Category

Examples in Robbins

Absorption / intake

Malabsorption; malnutrition

Vitamin inadequacy

Vitamin C and vitamin D deficiencies

Organ dysfunction

Hepatic insufficiency

Slide 42 · Secondary causes: Drug exposures

Medication / exposure

How to frame it

Corticosteroids

Recognized drug-associated bone loss

Anticonvulsants

Potential secondary contributor

Anticoagulants, chemotherapy

Listed among associated drug categories

Alcohol

Listed as an acquired exposure

Slide 43 · Secondary causes: Neoplastic and systemic

Category

Representative associated conditions

Neoplasia

Multiple myeloma; carcinomatosis

Miscellaneous

Anemia; immobilization; pulmonary disease

Hereditary skeletal disease

Osteogenesis imperfecta; homocystinuria

Slide 44 · Clinical assessment: Potential contributors

Interpret fragility in the context of age, menopause and physical activity.

Consider nutrition and medication exposures, particularly corticosteroids.

Look for clues to endocrine, gastrointestinal or neoplastic disease.

Primary and secondary categories should not be treated as mutually exclusive.

Slide 45 · The morphologic hallmark

The remaining bone tissue is histologically normal.

The amount of trabecular and/or cortical bone is reduced.

The architectural distribution differs with the dominant disease mechanism.

Loss of bone quantity ultimately reduces mechanical competence.

Slide 46 · Trabecular architecture: Normal and osteoporotic

Intact trabecular mesh

Thinned / disconnected trabeculae

Schematic — not a histologic specimen

Thinning and loss of trabecular plates diminish interconnected support.

This is an original structural schematic, not a photomicrograph.

Slide 47 · Trabecular perforation has a structural cost

Resorption can perforate trabecular plates.

Trabecular struts become thinner and may disappear.

Loss of cross-connections interrupts load-sharing pathways.

Microfracture risk increases before obvious vertebral collapse.

Slide 48 · Vertebral body failure under compression

Intact vertebral body

Compressed osteoporotic body

Vertical elements predominate after horizontal support is lost

Schematic — not an imaging study

The osteoporotic vertebral body can become shortened by compression fractures.

The source describes loss of horizontal trabeculae with relatively prominent vertical trabeculae.

Slide 49 · Why cancellous bone is vulnerable

Cancellous bone has extensive surface area exposed to remodeling.

Postmenopausal resorption prominently affects the vertebral cancellous compartment.

Perforation and loss of support link cellular hyperresorption to collapse.

The resulting fragility is architecture-dependent, not merely a radiographic appearance.

Slide 50 · Cortical bone: Thinning and enlarged canals

Relative cortical preservation

Cortical thinning / enlarged canals

Schematic cross-section — not histology

With senile osteoporosis, cortical loss occurs at endosteal and subperiosteal surfaces.

Haversian systems may become widened; Outer structural support is diminished.

Slide 51 · Senile cortical remodeling changes

Cortical thickness declines from endosteal and subperiosteal resorption.

Haversian canals become widened by internal resorption.

Reduced cortical cross-sectional support predisposes to mechanical failure.

Cortical changes coexist with loss of cancellous bone in advanced disease.

Slide 52 · Morphology: High- versus low-turnover patterns

Feature

Postmenopausal

Senile

Prominent change

Trabecular plates thin and perforate

Cortex thins; Haversian systems widen

Commonly emphasized site

Vertebral cancellous bone

Cortical compartments

Shared outcome

Less normally mineralized bone

Less normally mineralized bone

Slide 53 · Fracture is an architectural endpoint

Each trabecular disconnection reduces the redundancy of the load-bearing network.

Continued loss predisposes to microfracture and collapse.

In cortex, thinning impairs resistance to applied stresses.

Fractures may arise with comparatively modest mechanical loads.

Slide 54 · Vertebral fracture manifestations

Thoracic and lumbar vertebrae are important fracture sites.

Vertebral compression can cause back pain and loss of stature.

Multiple fractures alter spinal curvature and postural mechanics.

Kyphotic or other spinal deformities reflect repeated structural failure.

Slide 55 · Hip and pelvic fractures: Clinical consequences

Femoral neck and pelvic fractures can cause major loss of mobility.

Prolonged immobilization increases risk of medical complications.

The text highlights pneumonia and pulmonary embolism as major complications.

Clinical severity reflects downstream effects as well as the fracture itself.

Slide 56 · From fragility to systemic harm

Bone quantity declines

Structural fracture occurs

Mobility is lost

Medical complications emerge

The pathway is clinically important after vertebral, hip, pelvic or other major fractures.

Slide 57 · Osteoporosis can be clinically silent

The disease may progress without pain before a fracture.

Symptoms depend on the site and severity of structural failure.

Absence of symptoms does not demonstrate normal skeletal mass.

This limits symptom-based detection in asymptomatic people.

Slide 58 · Plain radiographs detect loss late

Routine radiographs are insensitive to early decreases in bone mass.

Substantial loss—approximately 30–40%—may precede reliable radiographic detection.

Conventional images are valuable for established fractures and deformity.

Normal-appearing radiographs do not exclude reduced bone density.

Slide 59 · Routine biochemical results may be normal

Serum calcium is usually normal in primary osteoporosis.

Serum phosphorus and alkaline phosphatase are also usually normal.

These results do not exclude loss of skeletal mass.

Abnormal biochemical findings may redirect evaluation toward an additional disorder.

Slide 60 · Imaging methods in the Robbins section

Method

What it contributes

Main limitation in this context

Plain radiograph

Depicts established loss and fracture

Insensitive before marked loss

Dual-energy X-ray absorptiometry (DXA)

Measures bone density

Density does not directly depict every architectural defect

Quantitative CT

Measures bone density

Requires specialized imaging

Slide 61 · Diagnostic reasoning: Mechanism to measurement

Clinical risk / fracture

Consider secondary causes

Quantify bone density

Integrate morphology and context

Conceptual approach based on the chapter; This is not a formal screening or treatment guideline.

Slide 62 · Osteoporosis and osteomalacia

Characteristic

Osteoporosis

Osteomalacia

Core defect

Reduced bone quantity

Impaired matrix mineralization

Residual bone

Normally mineralized

Undermineralized osteoid

Overlap

Both may predispose to fractures

Both may predispose to fractures

Slide 63 · Distinguishing other skeletal fragility mechanisms

Disorder

Principal difference from osteoporosis

Osteogenesis imperfecta

Defective type I collagen and inherited skeletal fragility

Osteopetrosis

Increased bone density due to impaired resorption; bone remains fragile

Hyperparathyroidism

Excess PTH-driven resorption can itself cause secondary osteopenia

Slide 64 · Prevention targets modifiable contributors

Adequate calcium and vitamin D support skeletal maintenance.

Exercise, including effective mechanical loading, can help preserve bone mass.

Immobility and inadequate nutritional intake are modifiable drivers.

Preventive measures address causes but do not fully reverse inherited or aging effects.

Slide 65 · Antiresorptive therapy: Principle

Increased osteoclast resorption is a therapeutic target.

Bisphosphonates as major resorption-reducing agents.

Treatment aims to reduce the imbalance responsible for progressive bone loss.

Specific prescribing regimens are outside the pathology scope of this lecture.

Slide 66 · Denosumab targets the RANKL pathway

RANKL

RANK on osteoclast precursor

Anti-RANKL antibody

Less osteoclast activation and bone resorption

Denosumab is an antibody directed against RANKL.

Blocking RANKL–RANK interaction inhibits osteoclast activation and resorption.

Slide 67 · Estrogen treatment requires a risk tradeoff

Estrogenic therapy can slow loss and reduce related fractures.

Venous thromboembolism and stroke as important concerns.

These complications restrict use of estrogen as osteoporosis treatment.

The pathologic mechanism does not by itself establish the correct treatment choice.

Slide 68 · Match intervention to the pathophysiology

Therapeutic approach

Targeted pathologic contribution

Loading / exercise

Low mechanical stimulation

Calcium and vitamin D adequacy

Nutritional contributions to low mass

Bisphosphonates

Osteoclast-mediated resorption

RANKL inhibition

Osteoclast recruitment through RANK signaling

Slide 69 · Application: Early postmenopausal bone loss

A previously healthy woman develops low bone density during the decade following menopause. Routine serum calcium is normal.

What cellular mechanism best explains accelerated loss?

Estrogen withdrawal increases pro-resorptive cytokine/RANKL signaling and osteoclast activity; Formation rises less than resorption.

Slide 70 · Application: Immobilized limb

A patient experiences prolonged loss of limb loading after paralysis; Regional imaging later demonstrates reduced skeletal mass.

Which bone cell senses the missing signal, and what distribution is expected?

Osteocytes sense mechanical loading; An unloaded extremity may develop localized disuse osteoporosis.

Slide 71 · Application: Vertebral deformity

An older patient develops progressive loss of height following repeated vertebral compression fractures.

Which microscopic architectural features create vertebral vulnerability?

Trabecular thinning, perforation, lost interconnections and microfractures weaken the cancellous framework.

Slide 72 · Application: A fragility fracture with normal chemistry

A patient with a low-trauma fracture has serum calcium, phosphate and alkaline phosphatase within laboratory reference limits.

Do these laboratory results rule out osteoporosis?

No. Routine calcium, phosphorus and alkaline phosphatase are commonly normal despite reduced bone mass.

Slide 73 · High-yield synthesis: Lesion and cause

Osteoporosis is quantitative loss of histologically normal, normally mineralized bone.

Peak mass reflects genetics, loading, nutrition and hormonal status.

Senile loss emphasizes inadequate formation; Postmenopausal loss emphasizes resorption.

Both pathways converge on fragile skeletal architecture.

Slide 74 · High-yield synthesis: Morphology and diagnosis

Trabecular thinning, perforation and loss of connections weaken vertebrae.

Cortical thinning and enlarged Haversian canals accompany age-related loss.

Fractures cause pain, deformity, loss of mobility and systemic complications.

DXA and quantitative CT assess density; Routine radiographs and blood chemistry can miss early disease.

Slide 75 · Source and further reading

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Chapter 26: Bones, Joints, and Soft Tissue Tumors.

“Osteopenia and Osteoporosis,” pp. 1070–1072, with preceding bone homeostasis/remodeling section (pp. 1065–1066).

Conceptual diagrams in this lecture are original editable schematics, not histologic specimens or reproduced textbook figures.

No clinical guideline updates or original chapter PDF figure verifications were incorporated.